Search results
Column: Pharmacy middlemen claim to keep prescription prices low. In fact, they've cost consumers...
Los Angeles Times· 7 hours agoIt was designed to massively overcharge customers by steering them to its affiliated or “preferred”...
FTC poised to sue drug middlemen over insulin prices
Axios· 7 hours agoWhy it matters: The planned suit, first reported by the Wall Street Journal, would follow a two-year FTC investigation that found pharmacy benefit...
FTC preparing suit against drug middlemen over insulin rebates
Los Angeles Times· 16 hours agoThe agency has been investigating whether the rebate practices of insulin manufacturers and three...
Biden health and human services chief rips pharmacy benefit managers during Flint visit
Detroit News· 17 hours agoU.S. Health and Human Services Secretary Xavier Becerra called for funding and policies that support...
Spotlight on PBMs gets harsher
Axios· 20 hours agoThe drumbeat for PBM reforms is intensifying, highlighted by a scathing Federal Trade Commission report on the industry's business practices and a coming...
US FTC to sue drug middlemen over insulin prices, source says
AOL· 23 hours ago(Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over their tactics as middlemen in negotiating prices for drugs including ...
FTC to sue drug managers amid insulin price hikes
Investing.com via Yahoo Finance Canada· 1 day agoInvesting.com - The Federal Trade Commission (FTC) is gearing up to sue the top three pharmacy-benefit managers (PBMs) over their strategies for negotiating drug prices, including insulin. This ...
Powell Cheers Markets Looking for Signs on Rate Cuts
New York Times· 1 day agoThe S&P 500 winning streak rolled on after the Fed chair made encouraging comments about inflation and the state of the labor market. The S&P 500 is on a...
Tesla, Apple Winning Streaks Are Built on AI Hope. Why Optimism Is Spreading and 4 Other Things to...
Barrons.com· 1 day agoCVS Caremark said limiting PBM negotiating tools would reward the pharmaceutical industry. Four of...
Ozempic's popularity leads to shortages for people with Type 2 diabetes
MPR News· 1 day agoJim Cox had heard of people with Type 2 diabetes who were unable to get Ozempic because the drug was being used off-label for weight loss. Telehealth company Ro built a free online tool to help patients report shortages of these drugs.